Regional white matter atrophy - Based classification of multiple sclerosis in cross-sectional and longitudinal data

American Journal of Neuroradiology

Volumn 30, Issue 9, 2009, Pages 1731-1739

  Sampat, M P ^a   Berger, A M ^a   Healy, B C ^a,b   Hildenbrand, P ^c   Vass, J ^a   Meier, D S ^a   Chitnis, T ^a   Weiner, H L ^a   Bakshi, R ^a   Guttmann, Charles R G ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALGORITHM; ARTICLE; BRAIN ATROPHY; CORPUS CALLOSUM; DECISION TREE; DISEASE DURATION; FEMALE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEDULLA OBLONGATA; MULTIPLE SCLEROSIS; WHITE MATTER;

ANATOMY, CROSS-SECTIONAL; ATROPHY; BRAIN; FEMALE; HUMANS; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NERVE FIBERS, MYELINATED;

EID: 70349909335     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: 10.3174/ajnr.A1659     Document Type: Article

References (56)

1. Miller DH, Barkhof F, Frank JA, et al., Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance. Brain 2002;125(pt 8):1676-1695 (Pubitemid 34885698)
2. Bermel RA, Bakshi R. The measurement and clinical relevance of brain atrophy in multiple sclerosis. Lancet Neurol 2006;5:158-170 (Pubitemid 43107851)
3. Hauser SL, Oksenberg JR. The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration. Neuron 2006;52:61-76 (Pubitemid 44466355)
4. Owens T. The enigma of multiple sclerosis: inflammation and neurodegeneration cause heterogeneous dysfunction and damage. Curr Opin Neurol 2003;16:259-265 (Pubitemid 36688291)
5. Peterson LK, Fujinami RS. Inflammation, demyelination, neurodegeneration and neuroprotection in the pathogenesis of multiple sclerosis. J Neuroimmunol 2007;184:37-44 (Pubitemid 46389415)
6. Miller DH, Leary SM. Primary-progressive multiple sclerosis. Lancet Neurol 2007;6:903-912
7. Ge Y. Multiple sclerosis: the role of MR imaging. AJNR Am J Neuroradiol 2006;27:1165-1176 (Pubitemid 44897620)
8. Miller DH. Biomarkers and surrogate outcomes in neurodegenerative disease: lessons from multiple sclerosis. NeuroRx 2004;1:284-294
9. Sailer M, Fischl B, Salat BD, et al. Focal thinning of the cerebral cortex in multiple sclerosis. Brain 2003;126(pt 8):1734-1744 (Pubitemid 36917333)
10. Bermel RA, Bakshi R, Tjoa RC, et al. Bicaudate ratio as a magnetic resonance imaging marker of brain atrophy in multiple sclerosis. Arch Neurol 2002;59:275-280 (Pubitemid 34240944)
11. Houtchens MK, Benedict RH, Killiany R, et al. Thalamic atrophy and cognition in multiple sclerosis. Neurology 2007;69:1213-1223 (Pubitemid 47429021)
12. Liptak Z, Berger AM, Sampat MP, et al. Medulla oblongata volume: a biomarker of spinal cord damage and disability in multiple sclerosis. AJNR Am J Neuroradiol 2008;29:1465-1470
13. Pelletier J, Suchet JL, Witjas T, et al. A longitudinal study of callosal atrophy and interhemispheric dysfunction in relapsing-remitting multiple sclerosis. Arch Neurol 2001;58:105-111 (Pubitemid 32053214)
14. Gauthier SA, Glanz BI, Mandel M, et al. A model for the comprehensive investigation of a chronic autoimmune disease: the multiple sclerosis CLIMB study. Autoimmun Rev 2006;5:532-536 (Pubitemid 44488756)
15. McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for Multiple Sclerosis: guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Ann Neurol 2001;50:121-127
16. Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria." Ann Neurol 2005;58:840-846
17. Lublin FD, Reingold SC. Defining the clinical course of multiple sclerosis: results of an international survey-National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 1996;46:907-911
18. Wei X, Warfield SK, Zou KH, et al. Quantitative analysis of MRI signal abnormalities of brain white matter with high reproducibility and accuracy. J Magn Reson Imaging 2002;15:203-209 (Pubitemid 34112912)
19. Warfield SK, Kaus M, Jolesz FA, et al. Adaptive, template moderated, spatially varying statistical classification. Med Image Anal 2000;4:43-55
20. Guttmann CR, Kikinis R, Anderson MC, et al. Quantitative follow-up of patients with multiple sclerosis using MRI: reproducibility. J Magn Reson Imaging 1999;9:509-518 (Pubitemid 29194288)
21. Luft AR, Skalej M, Schulz JB, et al. Patterns of age-related shrinkage in cerebellum and brainstem observed in vivo using three-dimensional MRI volumetry. Cereb Cortex 1999;9:712-721
22. Murshed KA, Ziylan T, Seker TM, et al. Morphometric assessment of brain stem und cerebellar vermis with midsagittal MRI: the gender differences and effects of age. Neuroanatomy 2003;2:35-38 (Pubitemid 38744696)
23. Rashid W, Davies GR, Chard DT, et al. Increasing cord atrophy in early relapsing-remitting multiple sclerosis: a 3 year study. J Neurol Neurosurg Psychiatry 2006;77:51-55 (Pubitemid 43022690)
24. Vaithianathar L, Tench CR, Morgan PS, et al. Magnetic resonance imaging of the cervical spinal cord in multiple sclerosis: a quantitative T1 relaxation time mapping approach. J Neurol 2003;250:307-315 (Pubitemid 36399270)
25. Liu C, Edwards CS, Gong Q, et al. Three dimensional MRI estimates of brain and spinal cord atrophy in multiple sclerosis. J Neurol Neurosurg Psychiatry 1999;66:323-330 (Pubitemid 29103486)
26. Rashid W, Davies GR, Chard DT, et al. Upper cervical cord area in early relapsing-remitting multiple sclerosis: cross-sectional study of factors influencing cord size. J Magn Reson Imaging 2006;23:473-476
27. Hofer S, Frahm, J. Topography of the human corpus callosum revisited: comprehensive fiber tractography using diffusion tensor magnetic resonance imaging. Neuroimage 2006;32:989-994 (Pubitemid 44278703)
28. Duda RO, Hart PE, Stork DG. Pattern Classification. 2nd ed. New York: Wiley- InterScience; 2000
29. Bieniek M, Altmann DR, Davies GR, et al. Cord atrophy separates early primary progressive and relapsing remitting multiple sclerosis. J Neurol Neurosurg Psychiatry 2006;77:1036-1039 (Pubitemid 44338524)
30. Losseff NA, Webb SL, O'Riordan JI, et al. Spinal cord atrophy and disability in multiple sclerosis: a new reproducible and sensitive MRI method with potential to monitor disease progression. Brain 1996;119(pt 3):701-708
31. Filippi M, Campi MA, Colombo B, et al.Aspinal cord MRI study of benign and secondary progressive multiple sclerosis. J Neurol 1996;243:502-505 (Pubitemid 26239702)
32. Tench CR, Morgan PS, Jaspan T, et al. Spinal cord imaging in multiple sclerosis. J Neuroimaging 2005;15(4 suppl):94S-102S (Pubitemid 43010535)
33. Stevenson VL, Leary SM, Losseff NA, et al. Spinal cord atrophy and disability in MS: a longitudinal study. Neurology 1998;51:234-238 (Pubitemid 28345389)
34. Kidd D, Thorpe JW, Thompson AJ, et al. Spinal cord MRI using multi-array coils and fast spin echo. II. Findings in multiple sclerosis. Neurology 1993;43:2632-2637 (Pubitemid 24004558)
35. Simon JH, Jacobs LD, Campion MK, et al. A longitudinal study of brain atrophy in relapsing multiple sclerosis: The Multiple Sclerosis Collaborative Research Group (MSCRG). Neurology 1999;53:139-148
36. Audoin B, Ibarrola D, Malikova I, et al. Onset and underpinnings of white matter atrophy at the very early stage of multiple sclerosis: a two-year longitudinal MRI/MRSI study of corpus callosum. Mult Scler 2007;13:41-51 (Pubitemid 46152760)
37. Martola J, Stawiarz JL, Fredrikson S, et al. Progression of non-age-related callosal brain atrophy in multiple sclerosis: a 9-year longitudinal MRI study representing four decades of disease development. J Neurol Neurosurg Psychiatry 2007;78:375-380
38. Evangelou N, Esiri, MM, Smith S, et al. Quantitative pathological evidence for axonal loss in normal appearing white matter in multiple sclerosis. Ann Neurol 2000;47:391-395 (Pubitemid 30141854)
39. Witelson SF. Hand and sex differences in the isthmus and genu of the human corpus callosum: a postmortem morphological study. Brain 1989;112(pt 3):799-835
40. Jokinen H, Ryberg C, Kalska H, et al. Corpus callosum atrophy is associated with mental slowing and executive deficits in subjects with age-related white matter hyperintensities: the LADIS Study. J Neurol Neurosurg Psychiatry 2007;78:491-496 (Pubitemid 46662897)
41. Huijbregts SC, Kalkers NF, de Sonneville LM, et al. Differences in cognitive impairment of relapsing remitting, secondary, and primary progressive MS. Neurology 2004;63:335-339
42. Foong J, Rozewicz L, Chong WK, et al. A comparison of neuropsychological deficits in primary and secondary progressive multiple sclerosis. J Neurol 2000;247:97-101 (Pubitemid 30162522)
43. Comi G, Filippi M, Martinelli V, et al. Brain MRI correlates of cognitive impairment in primary and secondary progressive multiple sclerosis. J Neurol Sci 1995;132:222-227
44. Oh J, Pelletier D, Nelson SJ. Corpus callosum axonal injury in multiple sclerosis measured by proton magnetic resonance spectroscopic imaging. Arch Neurol 2004;61:1081-1086 (Pubitemid 38915950)
45. DeLuca GC, Ebers, GC, Esiri MM. Axonal loss in multiple sclerosis: a pathological survey of the corticospinal and sensory tracts. Brain 2004;127(pt 5):1009-1018
46. Gilmore CP, DeLuca GC, Bo L, et al. Spinal cord atrophy in multiple sclerosis caused by white matter volume loss. Arch Neurol 2005;62:1859-1862 (Pubitemid 41785079)
47. Ann Marrie R, Rudick RA. Drug insight: interferon treatment in multiple sclerosis. Nat Clin Pract Neurol 2006;2:34-44
48. Evangelou N, Konz D, Esiri MM, et al. Size-selective neuronal changes in the anterior optic pathways suggest a differential susceptibility to injury in multiple sclerosis. Brain 2001;124(pt 9):1813-1820 (Pubitemid 32845442)
49. Ciccarelli O, Werring DJ, Barker GJ, et al. A study of the mechanisms of normal-appearing white matter damage in multiple sclerosis using diffusion tensor imaging-evidence of wallerian degeneration. J Neurol 2003;250:287-292 (Pubitemid 36399267)
50. Coombs BD, Best A, Brown MS, et al. Multiple sclerosis pathology in the normal and abnormal appearing white matter of the corpus callosum by diffusion tensor imaging. Mult Scler 2004;10:392-397 (Pubitemid 39117334)
51. Ge Y, Law M, Johnson G, et al. Preferential occult injury of corpus callosum in multiple sclerosis measured by diffusion tensor imaging. JMRI 2004;20:1-7 (Pubitemid 38857510)
52. Lin X, Tench CR, Morgan PS, et al. Use of combined conventional and quantitative MRI to quantify pathology related to cognitive impairment in multiple sclerosis. J Neurol Neurosurg Psychiatr 2008;79:437-441
53. Mesaros S, Rocca MA, Riccitelli G, et al. Corpus callosum damage and cognitive dysfunction in benign MS. Hum Brain Mapp 2009;30:2656-2666
54. Raininko R, Autti T, Vanhanen SL, et al. The normal brain stem from infancy to old age. A morphometric MRI study. Neuroradiology 1994;36:364-368 (Pubitemid 24195622)
55. Mitchell TN, Free SL, Merschhemke M, et al. Reliable callosal measurement: population normative data confirm sex-related differences. AJNR Am J Neuroradiol 2003;24:410-418 (Pubitemid 36358994)
56. Sullivan EV, Rosenbloom MJ, Desmond JE, et al. Sex differences in corpus callosum size: relationship to age and intracranial size. Neurobiol Aging 2001;22:603-611 (Pubitemid 32607745)